Reported the development of biodegradable NPs containing streptomycin with high loading efficiency of 50% or higher for tuberculosis treatment. The NPs also can contain other aminoglycosides drugs, which are a known substrate for the multidrug efflux P-glycoprotein (Pgp). The gene discussed is PGP; the disease is tuberculosis.